NURO

NeuroMetrix Reports Q4 2012 Results

[Business Wire] – NeuroMetrix, Inc. , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financi moreView todays social media effects on NUROView the latest stocks trending across Twitter. Click to view dashboardSee who NeuroMetrix is hiring next, click here to view […]

Celestica Forms Advisory Council For Growing Healthcare Segment

[at noodls] – November 29, 2012 TORONTO, Canada – Celestica Inc. (NYSE, TSX: CLS), a global leader in the delivery of end-to-end product lifecycle solutions, today announced the company’s growing healthcare segment … moreView todays social media effects on NUROView the latest stocks trending across Twitter. Click to view dashboard […]